Comparing Horizant vs Tavneos
| Horizant (gabapentin enacarbil) | Tavneos (avacopan) |
|
|---|
| Horizant (gabapentin enacarbil) | Tavneos (avacopan) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Restless Legs Syndrome, Postherpetic Neuralgia. Horizant may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Granulomatosis with Polyangiitis, Microscopic Polyangiitis. Tavneos may also be used for purposes not listed in this medication guide. |
||||||||||||||||
| More about Horizant (gabapentin enacarbil) | More about Tavneos (avacopan) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Horizant has an average rating of 7.6 out of 10 from a total of 37 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 19% reported a negative effect. |
Tavneos has an average rating of 7.5 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 25% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Horizant side effects |
View all Tavneos side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Horizant prices |
View all Tavneos prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
6 hours |
97.6 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 270 drugs are known to interact with Horizant:
|
A total of 518 drugs are known to interact with Tavneos:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
April 06, 2011 |
October 07, 2021 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Requip
Requip is used to treat symptoms of Parkinson's disease, such as stiffness, tremors and muscle ...
Mirapex
Mirapex (pramipexole) treats the symptoms of Parkinson's disease and is also used to treat Restless ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Neupro
Neupro Skin Patches (rotigotine) are used to treat early signs and symptoms of Parkinson's disease ...
Inbrija
Inbrija is an inhaled medicine used to treat the symptoms of Parkinson's disease. Includes side ...
Requip XL
Requip XL is used for parkinson's disease, periodic limb movement disorder
Rotigotine
Rotigotine is used for parkinson's disease, restless legs syndrome
Levodopa
Levodopa is used for parkinson's disease, parkinsonism, periodic limb movement disorder, restless ...
Pramipexole
Pramipexole is used for parkinson's disease, periodic limb movement disorder, restless legs ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.